Sterling Capital Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.83K Sell
1,411
-1,085
-43% -$3.37K ﹤0.01% 2639
2026
Q1
$5.69K Buy
+2,496
New +$5.75K ﹤0.01% 2668
2025
Q4
Sell
-5,203
Closed -$25K 3261
2025
Q3
$25K Buy
5,203
+3,167
+156% +$20.1K ﹤0.01% 2034
2025
Q2
$18.5K Buy
2,036
+920
+82% +$6.78K ﹤0.01% 1822
2025
Q1
$10.1K Sell
1,116
-944
-46% -$9.97K ﹤0.01% 1860
2024
Q4
$26.9K Buy
2,060
+1,820
+758% +$24.3K ﹤0.01% 1790
2024
Q3
$3.77K Buy
+240
New +$3.64K ﹤0.01% 1875
2016
Q3
Sell
-7,034
Closed -$263K 950
2016
Q2
$263K Sell
7,034
-209
-3% -$7.86K ﹤0.01% 844
2016
Q1
$293K Buy
+7,243
New +$270K ﹤0.01% 825
2014
Q2
Sell
-19,864
Closed -$696K 913
2014
Q1
$696K Buy
19,864
+202
+1% +$7.13K 0.01% 688
2013
Q4
$719K Buy
19,662
+1,538
+8% +$56.4K 0.01% 458
2013
Q3
$627K Buy
18,124
+7,821
+76% +$274K 0.01% 331
2013
Q2
$349K Buy
+10,303
New +$342K ﹤0.01% 398

Other funds holding ACH

Sterling Capital Management's ACH Position: Q2 2026 in Review

Sterling Capital Management reduced its Accendra Health (ACH) stake by 43% in Q2 2026, selling an estimated $3.37K and leaving 1,411 shares worth $4.83K. The position accounts for ﹤0.01% of the portfolio, ranked #2639.

Sterling Capital Management first reported a position in ACH in Q2 2013 and has held it in 13 quarters since. The position peaked at $719K in Q4 2013. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Sterling Capital Management held 1,411 shares of Accendra Health worth $4.83K as of Q2 2026.
  • Sterling Capital Management sold 1,085 Accendra Health shares in Q2 2026, an estimated $3.37K.
  • Accendra Health made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2639 holding.
  • Sterling Capital Management first reported a position in Accendra Health in Q2 2013 and has held it in 13 quarters since.
  • Sterling Capital Management's Accendra Health position peaked at $719K in Q4 2013.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.